Zdrowie i gospodarka · 27/05/2022
FDA Releases Final Guidance for Developing Gonadotropin-Releasing Hormone Analogues for Advanced Prostate Cancer
The Food and Drug Administration (FDA) has released a final guidance for the pharmaceutical industry on developing gonadotropin-releasing hormone analogues to treat advanced prostate cancer, following the July 2019 draft guidance.